Compumed Stock Performance
| CMPD Stock | USD 3.02 0.25 7.65% |
The firm shows a Beta (market volatility) of 0.47, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, CompuMed's returns are expected to increase less than the market. However, during the bear market, the loss of holding CompuMed is expected to be smaller as well. At this point, CompuMed has a negative expected return of -0.1%. Please make sure to confirm CompuMed's kurtosis, and the relationship between the maximum drawdown and day median price , to decide if CompuMed performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CompuMed has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders. ...more
CompuMed |
CompuMed Relative Risk vs. Return Landscape
If you would invest 370.00 in CompuMed on September 28, 2025 and sell it today you would lose (68.00) from holding CompuMed or give up 18.38% of portfolio value over 90 days. CompuMed is currently does not generate positive expected returns and assumes 6.5835% risk (volatility on return distribution) over the 90 days horizon. In different words, 59% of pink sheets are less volatile than CompuMed, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
CompuMed Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for CompuMed's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as CompuMed, and traders can use it to determine the average amount a CompuMed's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0159
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | CMPD |
Based on monthly moving average CompuMed is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of CompuMed by adding CompuMed to a well-diversified portfolio.
CompuMed Fundamentals Growth
CompuMed Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of CompuMed, and CompuMed fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CompuMed Pink Sheet performance.
| Return On Equity | -0.3 | |||
| Return On Asset | -0.13 | |||
| Profit Margin | (0.02) % | |||
| Operating Margin | (0.08) % | |||
| Current Valuation | 4.12 M | |||
| Shares Outstanding | 1.11 M | |||
| Price To Earning | (8.36) X | |||
| Price To Book | 36.30 X | |||
| Price To Sales | 2.43 X | |||
| Revenue | 2.31 M | |||
| EBITDA | (45 K) | |||
| Cash And Equivalents | 4 K | |||
| Total Debt | 24.91 K | |||
| Debt To Equity | 1.28 % | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | 175.43 K | |||
| Earnings Per Share | (0.01) X | |||
| Total Asset | 835.02 K | |||
| Retained Earnings | (37.15 M) | |||
| Current Asset | 392 K | |||
| Current Liabilities | 248 K | |||
About CompuMed Performance
By analyzing CompuMed's fundamental ratios, stakeholders can gain valuable insights into CompuMed's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if CompuMed has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if CompuMed has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California. Compumed operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 8 people.Things to note about CompuMed performance evaluation
Checking the ongoing alerts about CompuMed for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for CompuMed help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CompuMed generated a negative expected return over the last 90 days | |
| CompuMed has high historical volatility and very poor performance |
- Analyzing CompuMed's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CompuMed's stock is overvalued or undervalued compared to its peers.
- Examining CompuMed's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CompuMed's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CompuMed's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CompuMed's pink sheet. These opinions can provide insight into CompuMed's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for CompuMed Pink Sheet analysis
When running CompuMed's price analysis, check to measure CompuMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuMed is operating at the current time. Most of CompuMed's value examination focuses on studying past and present price action to predict the probability of CompuMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuMed's price. Additionally, you may evaluate how the addition of CompuMed to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |